Thanh bên bài viết

PDF (English)
Đã xuất bản: 2025-05-30
Số lượt xem tóm tắt: 22
Số lượt xem PDF (English): 17
DOI: https://doi.org/10.52852/tcncyh.v190i5E16.3297
Số xuất bản
Tập 190 Số 5E16 (2025)
Chuyên mục
Các bài báo
Cách trích dẫn
Minh, P. H. ., Yen, T. P. ., Ngoc, T. T. H. ., Tuan, L. A. ., Huong, N. T. T. ., & Thanh, M. P. . (2025). In vitro antioxidant and cytotoxic potential of Eclipta prostrata L. aerial part extracts. Tạp Chí Nghiên cứu Y học, 190(5E16), 196-204. https://doi.org/10.52852/tcncyh.v190i5E16.3297

In vitro antioxidant and cytotoxic potential of Eclipta prostrata L. aerial part extracts

Phan Hong Minh, Ta Phuong Yen, Tran Thi Hong Ngoc, Le Anh Tuan, Nguyen Thuc Thu Huong, Mai Phuong Thanh

Nội dung chính của bài viết

Tóm tắt

The phytochemical exploration in medicinal plants is increasingly recognized for its diverse pharmacological benefits. This research aims to evaluate the antioxidant potential and anticancer properties of Eclipta prostrata L. (EPL) extracts on human breast adenocarcinoma (MCF7), hepatocellular carcinoma (HepG2), and human gastric carcinoma (MKN-7) cell lines. The dried plant material was extracted in 70% ethanol, n-hexane, ethyl acetate, and n-butanol solvents. The antioxidative properties of EPL extracts were assessed through ABTS and FRAP assays, while the antiproliferative effects were measured using the sulforhodamine B assay. Findings indicated that the ethyl acetate extract exhibited higher antioxidant and cytotoxic activities against the HepG2 cell line compared to other extracts. Future research should aim to isolate and characterize the specific bioactive compounds responsible for the observed anticancer and antioxidant effects, and clarify their mechanisms of action.

Chi tiết bài viết

Từ khóa

Eclipta prostrata, cytotoxicity, SRB, antioxidant, HepG2

Tài liệu tham khảo

1. Phaniendra A, Jestadi DB, Periyasamy L. Free radicals: properties, sources, targets, and their implication in various diseases. Indian J Clin Biochem. 2015;30(1):11-26. doi: 10.1007/s12291-014-0446-0.
2. Afzal S, Abdul Manap AS, Attiq A, et al. From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration. Front Pharmacol. 2023;14:1269581. doi: 10.3389/fphar.2023.1269581.
3. Tan BL, Norhaizan ME, Liew WP, et al. Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases. Front Pharmacol. 2018;9:1162. doi: 10.3389/fphar.2018.01162.
4. Gu X, Mu C, Zheng R, et al. The Cancer Antioxidant Regulation System in Therapeutic Resistance. Antioxidants (Basel). 2024;13(7):778. doi: 10.3390/antiox13070778.
5. Chunarkar-Patil P, Kaleem M, Mishra R, et al. Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies. Biomedicines. 2024;12(1):201. doi: 10.3390/biomedicines12010201.
6. Timalsina D, Devkota HP. Eclipta prostrata (L.) L. (Asteraceae): Ethnomedicinal Uses, Chemical Constituents, and Biological Activities. Biomolecules. 2021;11(11):1738. doi: 10.3390/biom11111738.
7. Orellana EA, Kasinski AL. Sulforhodamine B (SRB) Assay in Cell Culture to Investigate Cell Proliferation. Bio Protoc. 2016;6(21):e1984. doi: 10.21769/BioProtoc.1984.
8. Gavanji S, Bakhtari A, Famurewa AC, et al. Cytotoxic Activity of Herbal Medicines as Assessed in Vitro: A Review. Chem Biodivers. 2023;20(2):e202201098. doi: 10.1002/cbdv.202201098.
9. Re R, Pellegrini N, Proteggente A, et al. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999;26(9-10):1231-1237. doi: 10.1016/s0891-5849(98)00315-3.
10. Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999;299:15-27. doi: 10.1016/s0076-6879(99)99005-5.
11. Padmapriya R, Ashwini S, Raveendran R. In vitro antioxidant and cytotoxic potential of different parts of Tephrosia purpurea. Res Pharm Sci. 2017;12(1):31-37. doi: 10.4103/1735-5362.199044.
12. Khan T, Ali M, Khan A, et al. Anticancer Plants: A Review of the Active Phytochemicals, Applications in Animal Models, and Regulatory Aspects. Biomolecules. 2019;10(1):47. doi: 10.3390/biom10010047.
13. Das MK, Singh N, Rajamani P. Comprehensive Assessment of the Antioxidant and Anticancer Potential of Selected Ethnobotanical Plants. Oxygen. 2023;3(2):203-221. doi: 10.3390/oxygen3020015.
14. Bach Le Thi, Thu Hanh Huynh, Kim Phuong Pham Thi, et al. Chemical compositions and antioxidant activities of Eclipta prostrata (L.) L. Can Tho University Journal of Science. 2024;60:299-304. doi: 10.22144/ctujos.2024.350.
15. Indrayanto G, Putra GS, Suhud F. Validation of in-vitro bioassay methods: Application in herbal drug research. Profiles Drug Subst Excip Relat Methodol. 2021;46:273-307. doi: 10.1016/bs.podrm.2020.07.005.
16. Canga I, Vita P, Oliveira AI, et al. In Vitro Cytotoxic Activity of African Plants: A Review. Molecules. 2022;27(15):4989. doi: 10.3390/molecules27154989.
17. Chaudhary H, Dhuna V, Singh J, et al. Evaluation of hydro-alcoholic extract of Eclipta alba for its anticancer potential: an in vitro study. J Ethnopharmacol. 2011;136(2):363-7. doi: 10.1016/j.jep.2011.04.066.
18. Singh A, Singh A, Dwivedi V. Screening of Hydro-alcoholic Extract of Eclipta alba for its Anticancerous Efficacy. International Journal of Science and Research. 2017;6(2):488-491.
19. Arya R, Singh A, Yadav N, et al. Anti-breast tumor activity of Eclipta extract in-vitro and in-vivo: novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosis. Sci Rep. 2016;5:18457. doi: 10.1038/srep18457.
20. Kim HY, Kim HM, Ryu B, et al. Constituents of the aerial parts of Eclipta prostrata and their cytotoxicity on human ovarian cancer cells in vitro. Arch Pharm Res. 2015;38(11):1963-1969. doi: 10.1007/s12272-015-0599-2.
21. Ha NM, Hop NQ, Son NT. Wedelolactone: A molecule of interests. Fitoterapia. 2023;164:105355. doi: 10.1016/j.fitote.2022.105355.